Funded Startups in Pompano Beach
In the 8 most recent Pompano Beach–based rounds shown, the disclosed amounts cluster around a few mid-size deals—except for one outlier.
In the 8 most recent Pompano Beach–based rounds shown, the disclosed amounts cluster around a few mid-size deals—except for one outlier. Boca Biolistics’ $25M round (2023-02-22) dwarfs the rest of the disclosed figures, which range down to $70K (LSX Capital Management, 2023-08-09) and include several values far below $25M (e.g., $3M for Lawvora on 2025-11-14 and $11M for Skyx Platforms on 2024-10-07).
Sector and stage signals also concentrate: four of the eight entries are biotechnology (LSX is financial services; the remaining include Lawvora in AI/B2B software and Xcyte Digital in events), and five of the eight rows list “Series Unknown” or an unspecified label (Xcyte Digital, Skyx Platforms, BioStem Technologies, Boca Biolistics, and Empowered Diagnostics). Temporally, rounds span 2020-09-14 (Stimwave Technologies, $800K) through 2025-11-14 (Lawvora, $3M), with two $3M rounds appearing across 2025 (Lawvora in November 2025 and Xcyte Digital in January 2025).
Most recent rounds
8 shownRelated listings
Frequently asked
Which disclosed round is the clear outlier, and how far above the next-largest amount is it?
Boca Biolistics’ $25M (2023-02-22) is the only round above $11M, with the next-largest disclosed amount being Skyx Platforms’ $11M (2024-10-07). That makes Boca Biolistics a standout versus the rest of the disclosed figures in this list.
Do biotechnology companies dominate this Pompano Beach funding slice, and what are the related deal sizes?
Biotechnology appears in 4 of the 8 entries: BioStem Technologies ($220K, 2023-04-04), Boca Biolistics ($25M, 2023-02-22), Empowered Diagnostics ($2M, 2022-07-11), and BioStem/Boca/Empowered’s cluster leaves other sectors (AI/B2B software, events, consumer electronics, financial services, hardware) as less frequent.
How concentrated are “Series Unknown” or unspecified stage labels in the recent rounds?
5 of the 8 rows carry “Series Unknown” or an unspecified stage (Xcyte Digital on 2025-01-23, Skyx Platforms on 2024-10-07, BioStem Technologies on 2023-04-04, Boca Biolistics on 2023-02-22, and Empowered Diagnostics on 2022-07-11). Only two entries show explicit labels beyond that framing: Lawvora’s Pre-Seed (2025-11-14) and LSX Capital Management’s Seed (2023-08-09), plus Stimwave Technologies with a blank stage on 2020-09-14.
What stage mix looks most “informative” versus ambiguous when comparing the listed labels and dates?
The few clearly labeled rounds are concentrated: Lawvora (Pre-Seed, $3M on 2025-11-14) and LSX Capital Management (Seed, $70K on 2023-08-09), while the majority of rounds across the span 2020-09-14 to 2025-11-14 are tagged Series Unknown/unspecified (e.g., Skyx Platforms $11M on 2024-10-07 and Empowered Diagnostics $2M on 2022-07-11).
Which rounds fall closest to the most recent date in this table, and do they show a tight funding level?
The most recent round date is 2025-11-14 (Lawvora, $3M). Within the following year in this table, another $3M appears on 2025-01-23 (Xcyte Digital, $3M), while the next disclosed tiers step up later (Skyx Platforms $11M on 2024-10-07 and Boca Biolistics $25M on 2023-02-22), suggesting some near-term repetition around $3M but not a sustained level at the top end.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.